NCT02902783

Brief Summary

The DONATE-Pilot is a prospective observational cohort study in organ donation (OD) that observes the ICU management of consented deceased organ donors at 4 high volume centres over a period of 12 months each. The pilot study will be followed by a 1-year prospective national observational study a 15-20 ICUs across Canada.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
177

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 7, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 16, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

March 26, 2018

Status Verified

February 1, 2018

Enrollment Period

1.5 years

First QC Date

September 7, 2016

Last Update Submit

March 22, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility

    This outcome is judged based on four elements: 1) Implementation of a waived consent model; 2) Refinement of data collection procedures for adult intensive care units; 3) Development of efficient links to post-transplantation data.

    After 1 year of recruitment at each participating site

Secondary Outcomes (2)

  • Description of current practices

    After 1 year of recruitment at each participating site

  • Effectiveness of various ICU interventions

    After 1 year of recruitment at each participating site

Study Arms (1)

Consented deceased organ donors

Data will be collected on deceased donors, declared by neurological determination of death (DND) and by circulatory determination of death (DCD).

Other: Data Collection

Interventions

Data collection relevant to this study will be obtained by observation and review of hospital charts. Limited data will be obtained through relevant organ donation organizations (ODOs).

Consented deceased organ donors

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients for whom consent for deceased organ donation has been obtained.

You may qualify if:

  • Admitted to a critical care area (ICU, PICU, CCU, ER)
  • Consented deceased organ donors (DND and DCD)

You may not qualify if:

  • Neonate \<36 weeks gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hamilton General Hospital

Hamilton, Ontario, L8L 2X2, Canada

Location

Centre de recherche CHUS

Sherbrooke, Quebec, J1H 5N4, Canada

Location

Related Publications (1)

  • D'Aragon F, Cook D, Dhanani S, Ribic C, Burns KEA, Akhtar A, Hand L, Arseneau E, Cupido C, Whittigham H, Healey A, Frenette AJ, Lamontagne F, Meade MO; Canadian Critical Care Trials Group and the Canadian National Transplant Research Program. Hamilton-DONATE: a city-wide pilot observational study of the ICU management of deceased organ donors. Can J Anaesth. 2018 Oct;65(10):1110-1119. doi: 10.1007/s12630-018-1179-y. Epub 2018 Jul 9.

Related Links

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Meade Maureen, MD, MSc

    McMaster University

    STUDY DIRECTOR
  • Frederick D'Aragon, MD, MSc

    Université de Sherbrooke

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2016

First Posted

September 16, 2016

Study Start

September 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

March 26, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations